Paolo Righi

This inventor holds 11 USPTO granted patents and 20 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Alfa Wassermann, Inc.. Active years: 2006-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paolo Righi. Retrieved from https://idiyas.com/inventor/paolo-righi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 20)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 7.0

ph-index = 10

Forward Citations = 267(Granted Patents)

Company Filing History:

11 out of 88

Alfa Wassermann, Inc.

patents

Years Active: 2006-2014

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8853231 - Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin (2014-10-07),

2. 8835452 - Polymorphic forms α, β and γ of rifaximin (2014-09-16),

3. 8765778 - Rifamycin derivatives (2014-07-01),

4. 8173801 - Processes for the production of polymorphic forms of rifaximin (2012-05-08),

5. 8158781 - Polymorphic forms α, β and γ of rifaximin (2012-04-17),

6. 8158644 - Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin (2012-04-17),

7. 7923553 - Processes for the production of polymorphic forms of rifaximin (2011-04-12),

8. 7906542 - Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin (2011-03-15),

9. 7902206 - Polymorphic forms α, β and γ of rifaximin (2011-03-08),

10. 7612199 - Polymorphic forms α, β, and γ of rifaximin (2009-11-03),

11. 7045620 - Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparations (2006-05-16),

Title: Biography of Inventor Paolo Righi

Introduction

Paolo Righi is a notable inventor based in Bologna, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of polymorphic forms of rifaximin. With a total of 11 patents to his name, Righi's work has had a considerable impact on medicinal formulations.

Latest Patents

His latest patents include innovative pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin. These crystalline polymorphous forms, referred to as rifaximin α and rifaximin β, along with a poorly crystalline form known as rifaximin γ, are essential for producing medicaments for both oral and topical use. The invention details a crystallization process that involves hot-dissolving raw rifaximin in ethyl alcohol and inducing crystallization through the addition of water at specific temperatures and durations, followed by controlled drying to achieve a precise water content in the final product.

Career Highlights

Throughout his career, Paolo Righi has worked with prominent companies in the pharmaceutical industry, including Alfa Wassermann S.p.a. and Severini, Denis. His expertise in the field has allowed him to develop innovative solutions that enhance the efficacy of medicinal products.

Collaborations

Righi has collaborated with several professionals in his field, including Manuela Campana and Goffredo Rosini. These collaborations

Profile summary based on public USPTO records.